Thirumalai Chemicals Limited (TCL) has reported a significant operational challenge at its step-down subsidiary, Optimistic Organic Sdn Bhd (OOSB). The company's Maleic Anhydride unit is experiencing a prolonged outage due to machinery failure, which has led to a substantial impact on the group's revenue.

Key Impacts of the Outage

• Revenue Contribution: The Maleic Anhydride unit contributed INR 235.00 crore, representing 9.60% of TCL's consolidated revenue.
• Current Financial Impact: Approximately INR 118.00 crore revenue reduction has already been recorded in H1 due to the ongoing outage.
• Consolidated Net Worth: The unit constituted about INR 140.00 crore, or 4.00% of the consolidated net worth.

Operational Status and Response

• Derivatives Plant: Despite the Maleic Anhydride unit's outage, OOSB's derivatives plant continues to operate.
• Recovery Efforts: The company is taking necessary steps, including seeking expert consultation, to determine the best course of action for restoring operations.

Financial Implications

The extended outage is expected to have a significant impact on TCL's financial performance. Here's a breakdown of the financial implications:

Insurance and Damage Assessment

• Insurance Coverage: The company has reported that the loss or damage is not covered by insurance.
• Damage Quantification: The actual reduction in revenue of approximately INR 118.00 crore in H1 serves as an indicator of the financial impact of the outage.

Looking Ahead

While Thirumalai Chemicals has not provided a specific timeline for the resolution of the machinery failure, it has emphasized that all necessary steps are being taken to address the situation. The prolonged nature of the outage suggests that the impact may continue to be felt in the coming quarters.

Investors and stakeholders will likely be keeping a close eye on Thirumalai Chemicals' future updates regarding the progress of repairs and the potential long-term effects on the company's financial performance. The ability of the company to mitigate the revenue loss through its other operations, particularly the continuing derivatives plant, will be crucial in the interim period.

Thirumalai Chemicals Limited has reported significant progress in utilizing funds from its recent preferential issue, according to the latest Monitoring Agency Report for the quarter ended September 30, 2025. The company has deployed Rs 311.11 crore out of the total Rs 450.63 crore raised, with no deviations from the stated objectives.

Capital Expenditure and Operational Payments

The company has allocated Rs 211.94 crore towards capital expenditure for its US subsidiary, TCL Specialties LLC. This investment aligns with Thirumalai Chemicals' strategy to expand its presence in the United States market.

Additionally, Rs 99.17 crore has been utilized for operational payments, including:

Fund Utilization and Monitoring

CRISIL Ratings, acting as the Monitoring Agency, has confirmed that there are no deviations from the stated objectives of the preferential issue. The remaining Rs 139.52 crore is currently held across various bank accounts of the company and its subsidiaries:

Project Timeline and Utilization

The company aims to complete the investment in TCL Specialties LLC by December 2025, as originally planned. However, there is a slight delay in utilizing funds for general corporate purposes, which was initially scheduled for October 2025 but is now expected to be completed by November 2025.

Additional Developments

In a separate disclosure, Thirumalai Chemicals has received an intimation of tax ascertained as being payable under Section 73 of the CGST Act, 2017. The Assistant Commissioner (ST), Ranipet, Tamil Nadu, has raised a demand of Rs 47.53 crore for excess Input Tax Credit (ITC) availed based on GSTR 9 scrutiny.

The company believes that the tax demand is erroneous and not sustainable. Thirumalai Chemicals plans to pursue legal remedies and expects any potential financial implications to be insignificant, with no material impact on its financial position.

This report demonstrates Thirumalai Chemicals' commitment to transparent fund utilization and strategic expansion, while also highlighting its proactive approach to addressing regulatory challenges.